These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 30170376)

  • 1. Proposed cut-off for reactivity of anti-HMGCR and anti-SRP antibodies in patients statin-exposed and statin-unexposed.
    Carvalho AAS; Silva VGD; Vieira TF; Delgado PO; Corazini R; Feder D; Fonseca FLA
    Medicine (Baltimore); 2018 Aug; 97(35):e11858. PubMed ID: 30170376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical features and prognosis in anti-SRP and anti-HMGCR necrotising myopathy.
    Watanabe Y; Uruha A; Suzuki S; Nakahara J; Hamanaka K; Takayama K; Suzuki N; Nishino I
    J Neurol Neurosurg Psychiatry; 2016 Oct; 87(10):1038-44. PubMed ID: 27147697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spectrum of immune-mediated necrotizing myopathies and their treatments.
    Pinal-Fernandez I; Mammen AL
    Curr Opin Rheumatol; 2016 Nov; 28(6):619-24. PubMed ID: 27607340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Statin-naïve anti-HMGCR antibody-mediated necrotizing myopathy in China.
    Jiao Y; Cai S; Lin J; Zhu W; Xi J; Li J; Yue D; Zhang T; Qiao K; Wang Y; Zhao C; Lu J
    J Clin Neurosci; 2018 Nov; 57():13-19. PubMed ID: 30205933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autoantibodies against 3-hydroxy-3-methylglutaryl-coenzyme A reductase in patients with statin-associated autoimmune myopathy.
    Mammen AL; Chung T; Christopher-Stine L; Rosen P; Rosen A; Doering KR; Casciola-Rosen LA
    Arthritis Rheum; 2011 Mar; 63(3):713-21. PubMed ID: 21360500
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Statins and myotoxic effects associated with anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase autoantibodies: an observational study in Japan.
    Watanabe Y; Suzuki S; Nishimura H; Murata KY; Kurashige T; Ikawa M; Asahi M; Konishi H; Mitsuma S; Kawabata S; Suzuki N; Nishino I
    Medicine (Baltimore); 2015 Jan; 94(4):e416. PubMed ID: 25634171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-HMGCR antibodies demonstrate high diagnostic value in the diagnosis of immune-mediated necrotizing myopathy following statin exposure.
    Shovman O; Gilburd B; Chayat C; Lazar AD; Amital H; Blank M; Bentow C; Mahler M; Shoenfeld Y
    Immunol Res; 2017 Feb; 65(1):276-281. PubMed ID: 27618830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibody levels correlate with creatine kinase levels and strength in anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase-associated autoimmune myopathy.
    Werner JL; Christopher-Stine L; Ghazarian SR; Pak KS; Kus JE; Daya NR; Lloyd TE; Mammen AL
    Arthritis Rheum; 2012 Dec; 64(12):4087-93. PubMed ID: 22933019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-hydroxy-3-methylglutaryl-coenzyme A reductase (anti-HMGCR) antibody in necrotizing myopathy: treatment outcomes, cancer risk, and role of autoantibody level.
    Aggarwal R; Moghadam-Kia S; Lacomis D; Malik A; Qi Z; Koontz D; Burlingame RW; Oddis CV
    Scand J Rheumatol; 2020 Sep; 49(5):405-411. PubMed ID: 31801390
    [No Abstract]   [Full Text] [Related]  

  • 10. [Screening of autoantibodies associated with necrotizing myopathy among undiagnosed chronic myopathy].
    Kuru S; Suzuki S; Ogata K; Kobayashi M; Ishida C; Watanabe C; Matsumura T
    Rinsho Shinkeigaku; 2017 Oct; 57(10):562-566. PubMed ID: 28954975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Longitudinal Course of Disease in a Large Cohort of Myositis Patients With Autoantibodies Recognizing the Signal Recognition Particle.
    Pinal-Fernandez I; Parks C; Werner JL; Albayda J; Paik J; Danoff SK; Casciola-Rosen L; Christopher-Stine L; Mammen AL
    Arthritis Care Res (Hoboken); 2017 Feb; 69(2):263-270. PubMed ID: 27111848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Statins and myositis: the role of anti-HMGCR antibodies.
    Selva-O'Callaghan A; Alvarado-Cardenas M; Marin A; Pinal-Fernandez I
    Expert Rev Clin Immunol; 2015; 11(12):1277-9. PubMed ID: 26492593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Immune-Mediated Necrotizing Myopathy].
    Uruha A
    Brain Nerve; 2024 May; 76(5):646-654. PubMed ID: 38741508
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Bergua C; Chiavelli H; Allenbach Y; Arouche-Delaperche L; Arnoult C; Bourdenet G; Jean L; Zoubairi R; Guerout N; Mahler M; Benveniste O; Drouot L; Boyer O
    Ann Rheum Dis; 2019 Jan; 78(1):131-139. PubMed ID: 30309969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential Pathogenic Role of Anti-Signal Recognition Protein and Anti-3-hydroxy-3-methylglutaryl-CoA Reductase Antibodies in Immune-Mediated Necrotizing Myopathies.
    Ladislau L; Arouche-Delaperche L; Allenbach Y; Benveniste O
    Curr Rheumatol Rep; 2018 Aug; 20(9):56. PubMed ID: 30074107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploring necrotizing autoimmune myopathies with a novel immunoassay for anti-3-hydroxy-3-methyl-glutaryl-CoA reductase autoantibodies.
    Drouot L; Allenbach Y; Jouen F; Charuel JL; Martinet J; Meyer A; Hinschberger O; Bader-Meunier B; Kone-Paut I; Campana-Salort E; Eymard B; Tournadre A; Musset L; Sibilia J; Marie I; Benveniste O; Boyer O;
    Arthritis Res Ther; 2014 Feb; 16(1):R39. PubMed ID: 24484965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical associations of patients with anti-3-hydroxy-3-methylglutaryl CoA reductase antibody-associated immune-mediated necrotising myopathy.
    Tan E; Knight J; Khonasti S; Nolan D; McGettigan B; Bundell C; Needham M; Brusch A
    Intern Med J; 2023 Oct; 53(10):1846-1853. PubMed ID: 36625419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune-Mediated Necrotizing Myopathy.
    Pinal-Fernandez I; Casal-Dominguez M; Mammen AL
    Curr Rheumatol Rep; 2018 Mar; 20(4):21. PubMed ID: 29582188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autoimmune necrotising myopathy and HMGCR antibodies.
    Karunaratne K; Amiras D; Pickering MC; Hofer M; Viegas S
    Pract Neurol; 2018 Apr; 18(2):151-155. PubMed ID: 29439058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathogenic role of anti-signal recognition protein and anti-3-Hydroxy-3-methylglutaryl-CoA reductase antibodies in necrotizing myopathies: Myofiber atrophy and impairment of muscle regeneration in necrotizing autoimmune myopathies.
    Arouche-Delaperche L; Allenbach Y; Amelin D; Preusse C; Mouly V; Mauhin W; Tchoupou GD; Drouot L; Boyer O; Stenzel W; Butler-Browne G; Benveniste O
    Ann Neurol; 2017 Apr; 81(4):538-548. PubMed ID: 28224701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.